- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patent holdings for IPC class C07D 519/00
Total number of patents in this class: 9709
10-year publication summary
|
524
|
616
|
633
|
662
|
760
|
815
|
969
|
1035
|
994
|
546
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4725 |
191 |
| Hoffmann-La Roche Inc. | 3777 |
184 |
| Gilead Sciences, Inc. | 2219 |
165 |
| Merck Sharp & Dohme LLC | 3734 |
165 |
| Incyte Corporation | 1072 |
161 |
| F. Hoffmann-La Roche AG | 7838 |
134 |
| Janssen Pharmaceutica N.V. | 3175 |
125 |
| Merck Patent GmbH | 5725 |
124 |
| Genentech, Inc. | 4101 |
115 |
| Boehringer Ingelheim International GmbH | 4502 |
111 |
| Takeda Pharmaceutical Company Limited | 2713 |
104 |
| Pfizer Inc. | 3380 |
101 |
| Amgen Inc. | 4418 |
91 |
| Novartis AG | 10279 |
78 |
| Idemitsu Kosan Co., Ltd. | 4228 |
64 |
| Array BioPharma Inc. | 448 |
63 |
| Revolution Medicines, Inc. | 327 |
62 |
| Samsung Display Co., Ltd. | 38544 |
59 |
| ImmunoGen, Inc. | 378 |
55 |
| Medshine Discovery Inc. | 587 |
55 |
| Other owners | 7502 |